Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant real-world study in adult insomnia with or without mild depressive-anxiety symptoms
ChiCTR2600120809Phase 4Recruiting
- Sponsor
- Affiliated Brain Hospital of Nanjing Medical University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lemborexant in Insomnia, sponsored by Affiliated Brain Hospital of Nanjing Medical University. Primary endpoint: Athens Insomnia Scale. Started Mar 2026; status: recruiting.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2600120809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120809.